SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-024841
Filing Date
2017-05-05
Accepted
2017-05-05 16:17:26
Documents
52
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v465327_10-q.htm 10-Q 376339
2 EXHIBIT 31.1 v465327_ex31-1.htm EX-31.1 7429
3 EXHIBIT 31.2 v465327_ex31-2.htm EX-31.2 7396
4 EXHIBIT 32.1 v465327_ex32-1.htm EX-32.1 3991
5 EXHIBIT 32.2 v465327_ex32-2.htm EX-32.2 4118
  Complete submission text file 0001144204-17-024841.txt   2841834

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eyeg-20170331.xml EX-101.INS 458244
7 XBRL TAXONOMY EXTENSION SCHEMA eyeg-20170331.xsd EX-101.SCH 30002
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eyeg-20170331_cal.xml EX-101.CAL 31504
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eyeg-20170331_def.xml EX-101.DEF 205017
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyeg-20170331_lab.xml EX-101.LAB 258427
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyeg-20170331_pre.xml EX-101.PRE 239878
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 17818608
SIC: 2834 Pharmaceutical Preparations